CJC 1295 — Research Summary
CJC 1295 is a growth hormone releasing hormone analogue peptide featuring strategic amino acid modifications that enhance stability for laboratory research applications. This synthetic peptide, available through Stroid UK Shop, enables researchers to investigate growth hormone axis modulation and receptor binding mechanisms in controlled laboratory environments. The compound represents a modified GHRH(1-29) sequence incorporating substitutions at positions 2, 8, 15, and 27 that extend its research utility compared to native GHRH molecules.
Laboratory Applications
Research scientists utilise this peptide to examine growth hormone secretagogue pathways and receptor interactions in various experimental models. Studies have evaluated its binding affinity to GHRH receptors and subsequent signalling cascades involved in growth hormone release. The compound’s structural modifications make it particularly valuable for investigating peptide stability and bioavailability parameters. Researchers working with CJC 1295 formulations often incorporate this variant into comparative studies examining different GHRH analogues. Laboratory investigations frequently examine its effects on cellular signalling pathways and receptor expression patterns. Scientists studying peptide research compounds appreciate its well-characterised molecular structure for reproducible experimental protocols. The 5mg format provides sufficient material for multiple research applications while maintaining cost-effectiveness for laboratory budgets. Research groups investigating growth hormone biology often combine this compound with other secretagogues available through research chemical suppliers to examine synergistic effects and pathway interactions.
Technical Specifications
| Parameter | Value |
|---|---|
| Molecular Weight | 3367.97 g/mol |
| CAS Number | 863288-34-0 |
| Purity | Verify with supplier |
| Format | Lyophilised powder |
| Storage | -20°C recommended |
| Solubility | Water soluble |
Research Compliance
This CJC 1295 5mg preparation from Axiom Peptides is manufactured exclusively for in-vitro research applications and laboratory studies. The compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper laboratory protocols, safety measures, and regulatory compliance when handling this research chemical. All studies should be conducted by qualified personnel in appropriate laboratory facilities with proper ventilation and safety equipment.
